Current Market Update

From Cabot Top Ten Trader Today's weakness cracked the market's intermediate-term uptrend, though because we've been cautious for a while, we're not changing our overall viewpoint—you should be holding some cash and going slow as the market and leaders work through this correction. That we...
Read More

Cabot Stock of the Week 316

Technically, the market is now in an intermediate-term downtrend, which tells us that additional defensive measures would be prudent. In the very short term, however, I expect a bounce from today’s high-profile decline, so I’m mainly holding.
Read More

Cabot Early Opportunities 113

Stock Name Market Cap Price Investment Type Kinsale Capital (KNSL) $4.2 billion 191.94 Rapid Growth – P&C Insurance Nevro (NVRO) $4.9 billion 144.55 Rapid Growth – MedTech Peloton (PTON) $24.7 billion 85.45 Rapid Growth – Exercise Equipment Varonis (VRNS) $3.6 billion 112.46 Rapid Growth – Software Vital Farms (VITL) $1.5 billion 36.65 Rapid Growth – Eggs & Butter Time Is on Our Side In 1964 the Rolling Stones their...
Read More

Cabot Prime Week Ending September 18, 2020

Stock Recommendation Tracker The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More

Cabot Growth Investor 1454

Burden of Proof is On the Bulls At heart, we’re students of the market, which means one of the key tools we use is spotting the difference between normal, run-of-the-mill action and abnormal, noteworthy action, the latter of which is what usually causes us make...
Read More

Cabot Prime Week Ending September 11, 2020

Stock Recommendation Tracker The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More

Cabot Undervalued Stocks Advisor 920

Don’t Fight the Fed? The U.S. Federal Reserve Bank, called by its colloquial name “the Fed” even on its website, made its informal but landmark policy change official last week. For the foreseeable future, the Fed will keep interest rates near zero, focusing almost on...
Read More

Cabot Prime Week Ending September 4, 2020

Stock Recommendation Tracker The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More

Cabot Growth Investor 1453

Has the “Re-Rotation” Begun? When our last issue went to press, growth stocks were under pressure. It wasn’t an epic disaster, but there had clearly been a change in character, with the initial market leaders (those that burst to new highs in April or May)...
Read More

Cabot Early Opportunities 112

Stock Name Market Cap Price Investment Type Altair Engineering (ALTR) $3.0 billion 42.25 Growth – Industrial Software Azek (AZEK) $6.0 billion 38.76 Growth – Construction Materials Jamf (JAMF) $4.5 billion 38.54 Rapid Growth – Software Nikola (NKLA) $14.9 billion 39.18 Development – Electric/Hydrogen Auto TFF Pharma (TFFP) $271 million 12.98 Development – Biotech Is The Hydrogen Economy Becoming Reality? Hydrogen has been a hot topic among investors lately of...
Read More